Medtronic PLC vs Snowflake Inc — how do they compare? Medtronic PLC trades at $87.7 (market cap $112.24B), while Snowflake Inc trades at $356.7 (market cap $121.15B). The key difference: Medtronic PLC and Snowflake Inc are close in size by market cap, and Medtronic PLC pays a 3.28% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Snowflake Inc for 54 Days on average.
| MDT | SNOW | |
|---|---|---|
Market Cap | $112.24B | $121.15B |
Volume | 105,663,236 | 3,986,549 |
Sector | Health | Technology |
52-Week High | $105.35 | $356.47 |
52-Week Low | $73.75 | $121.11 |
Typical Hold Time | 63 Days | 54 Days |
Enterprise Value | $131.58B | $121.57B |
Dividend Yield | 3.28% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.
MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.
Snowflake (SNOW) trades at $332.85, down 0.92% on the day, with technical indicators showing a neutral bias amid strong analyst support. The company demonstrates robust revenue growth, reaching $3.63 billion in 2025, but continues to post significant net losses (-$1.29 billion). Recent developments include a $3.75 billion convertible note offering and expanded partnerships, positioning the company for future growth in the AI data cloud market.
Snowflake presents a compelling growth story with strong revenue momentum and dominant market positioning, though profitability remains a key challenge. The stock offers 25% upside to the consensus price target of $418.03, supported by overwhelming analyst bullishness (81% buy ratings). However, investors face risks from ongoing losses, high valuation multiples, and competitive pressures in the cloud data sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →